News
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...
Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday. With the addition ...
Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
Doctors have explained what the 'golden dosing' trend does to your body as Ozempic and Mounjaro rise in popularity for weight ...
Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...
A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...
Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results